Evidence map›Paper›PMID 42819829›Full record

ArticleACS omega2026

Discovery and Characterization of Neuroactive Secondary Metabolites from

Sahar Mofidi Tabatabaei, Christian Kuete Fofie, Aliance Romain Fokoua, Alex Junior Kamtcha Yamdjieu, Patrick Walsh, Gregory Dussor, Télesphore Benoît Nguelefack, Benedict James Kolber, Kevin Joseph Tidgewell

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sahar Mofidi TabatabaeiDepartment of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky 40506, United States.
Christian Kuete FofieDepartment of Neuroscience and Center for Advanced Pain Studies, University of Texas at Dallas, Richardson, Texas 75080-3021, United States.
Aliance Romain FokouaResearch Unit of Animal Physiology and Phytopharmacology, Faculty of Sciences, University of Dschang, P.O. Box 67 Dschang, Cameroon.
Alex Junior Kamtcha YamdjieuResearch Unit of Animal Physiology and Phytopharmacology, Faculty of Sciences, University of Dschang, P.O. Box 67 Dschang, Cameroon.
Patrick WalshAnatomic Incorporated, Minneapolis, Minnesota 55413, United States.
Gregory DussorDepartment of Neuroscience and Center for Advanced Pain Studies, University of Texas at Dallas, Richardson, Texas 75080-3021, United States.
Télesphore Benoît NguelefackResearch Unit of Animal Physiology and Phytopharmacology, Faculty of Sciences, University of Dschang, P.O. Box 67 Dschang, Cameroon.ORCID https://orcid.org/0000-0002-5006-6927
Benedict James KolberDepartment of Neuroscience and Center for Advanced Pain Studies, University of Texas at Dallas, Richardson, Texas 75080-3021, United States.ORCID https://orcid.org/0000-0001-8665-1805
Kevin Joseph TidgewellDepartment of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky 40506, United States.ORCID https://orcid.org/0000-0002-0501-2604

Funding

Understanding the role of anti-apolipoprotein A-I antibodies in atherosclerotic cardiovascular diseaseP20GM130456 · NIGMS · UNIVERSITY OF KENTUCKY · PI Jon Scott Thorson · 2020 to 2026
$18.7M
Bruker AVANCE NEO 600 MHz High-Performance Digital NMR SpectrometerS10OD028690 · OD · UNIVERSITY OF KENTUCKY · PI GARNEAU-TSODIKOVA, SYLVIE · 2020 to 2020
$1.4M
High content analgesic screening from human nociceptorsR61AT011938 · NCCIH · UNIVERSITY OF TEXAS DALLAS · PI DUSSOR, GREGORY O, KOLBER, BENEDICT J · 2023 to 2024
$540k
High content analgesic screening from human nociceptorsR33AT011938 · NCCIH · UNIVERSITY OF TEXAS DALLAS · PI DUSSOR, GREGORY O, KOLBER, BENEDICT J · 2024 to 2025
$534k
From traditional medicine to innovation: Discovering novel analgesics targeting calcium modulation from Cameroonian phytochemicalsR21AT013164 · NCCIH · UNIVERSITY OF KENTUCKY · PI KOLBER, BENEDICT J, NGUELEFACK, TELESPHORE BENOIT · 2024 to 2024
$361k
NCCIH NIH HHS R21 AT013164NCCIH NIH HHS R33 AT011938NCCIH NIH HHS R61 AT011938NIGMS NIH HHS P20 GM130456NIH HHS S10 OD028690
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42819829
PMCPMC13625071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.